SAB Biotherapeutics, Inc.
$2.53
-0.06 (-2.32%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -27.7%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Aug 2026
- -36.6%
Own SABS?
See how SABS contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.